METHODS: Descriptive and retrospective observational study.
METHODS: The pharmacotherapeutic history of 295 patients was analyzed following the criteria proposed by the Pharmaceutical Care Network Europe, using the Revisem® digital platform of the Muy Ilustre Colegio Oficial de Farmacéuticos (MICOF).
RESULTS: The mean age of the patients was 81.8 ± 11.1 years and 66.4% were women. At least one DRP was detected in 97.3% of patients. 46.9% of the DRP analyzed were interactions, of which 29.7% involved a PPI, with omeprazole being the most frequent. DRPs with PPI are significantly related to certain patient conditions and pharmacological groups, such as female sex, age over 54 years and polypharmacy.
CONCLUSIONS: The application of the Revisem® digital platform allows the detection of a high prevalence of DRP at the provincial level. The application of new technological tools to detect the prevalence of DRP is essential to optimize patient treatments.
方法:描述性和回顾性观察性研究。
方法:按照欧洲药学监护网络提出的标准,对295例患者的药物治疗史进行了分析。使用MuyIlustreColegioOficialdeFarméuticos(MICOF)的Revisem®数字平台。
结果:患者的平均年龄为81.8±11.1岁,66.4%为女性。在97.3%的患者中检测到至少一个DRP。分析的DRP中有46.9%是相互作用,其中29.7%涉及PPI,奥美拉唑是最常见的。PPI的DRP与某些患者状况和药物组显着相关,比如女性,年龄在54岁以上和多药房。
结论:使用Revisem®数字平台可以检测到省级DRP的高患病率。应用新技术工具来检测DRP的患病率对于优化患者治疗至关重要。